[1] Pennathur A,Gibson MK,Jobe BA,et al. Oesophageal carcinoma[J]. Lancet,2013,381(9864):400-412. [2] Kamangar F,Dores GM,Anderson WF. Patterns of cancer incidence,mortality,and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world[J]. J Clin Oncol,2006, 24(14):2137-2150. [3] Fan YJ,Song X,Li JL,et al. Esophageal and gastric cardia cancers on 4238 Chinese patients residing in municipal and rural regions:a histopathological comparison during 24-year period [J]. World J Surg,2008,32(9):1980-1988. [4] Liu S,Dai JY,Yao L,et al. Esophageal adenocarcinoma and its rare association with Barrett's esophagus in Henan,China [J]. PLoS One,2014,9(10):e110348. [5] Fang C,Lu L,Shi J,et al. Risk factors of early proximal gastric carcinoma in Chinese diagnosed with the WHO criteria [J]. J Dig Dis,2015. doi:10.1111/1751-2980.312240. [6] Wang LD,Zhou FY,Li XM,et al. Genome-wide association study of esophageal squamous cell carcinoma in Chinese subjects identifies susceptibility loci at PLCE1 and C20orf54[J]. Nat Genet,2010,42(9):759-763. [7] Frankel A,Armour N,Nancarrow D,et al. Genome-wide analysis of esophageal adenocarcinoma yields specific copy number aberrations that correlate with prognosis[J]. Genes Chromosomes Cancer,2014,53(4):324-338. [8] Dulak AM,Schumacher SE,van Lieshout J,et al. Gastrointestinal adenocarcinomas of the esophagus,stomach, and colon exhibit distinct patterns of genome instability and oncogenesis[J]. Cancer Res,2012,72(17):4383-4393. [9] Gu J,Ajani JA,Hawk ET,et al. Genome-wide catalogue of chromosomal aberrations in barrett's esophagus and esophageal adenocarcinoma:a high-density single nucleotide polymorphism array analysis[J]. Cancer Prev Res:Phila,2010,3(9):1176-1186. [10] Goel R,Muthusamy B,Pandey A,et al. Human protein reference database and human proteinpedia as discovery resources for molecular biotechnology[J]. Mol Biotechnol, 2011,48(1):87-95. [11] Chatr-Aryamontri A,Breitkreutz BJ,Oughtred R,et al. The BioGRID interaction database:2015 update[J]. Nucleic Acids Res,2015,43:470-478. [12] Smoot ME,Ono K,Ruscheinski J,et al. Cytoscape 2.8:new features for data integration and network visualization[J] . Bioinformatics,2011,27(3):431-432. [13] Wang Q,Ma C,Kemmner W. Wdr66 is a novel marker for risk stratification and involved in epithelial-mesenchymal transition of esophageal squamous cell carcinoma[J]. BMC Cancer, 2013,13:137. [14] Diakiw SM,D'Andrea RJ,Brown AL. The double life of KLF5:Opposing roles in regulation of gene-expression, cellular function,and transformation[J]. IUBMB Life,2013, 65(12):999-1011. [15] Singhi AD,Foxwell TJ,Nason K,et al. Smad4 loss in esophageal adenocarcinoma is associated with an increased propensity for disease recurrence and poor survival[J]. Am J Surg Pathol,2015,39(4):487-495. [16] Maslov S,Sneppen K. Specificity and stability in topology of protein networks[J]. Science,2002,296(5569):910-913. [17] Miller CT,Lin L,Casper AM,et al. Genomic amplification of MET with boundaries within fragile site FRA7G and upregulation of MET pathways in esophageal adenocarcinoma[J]. Oncogene,2006,25(3):409-418. [18] Nancarrow DJ,Handoko HY,Smithers BM,et al. Genome-wide copy number analysis in esophageal adenocarcinoma using high-density single-nucleotide polymorphism arrays[J]. Cancer Res,2008,68(11):4163-4172. [19] Langer R,Von Rahden BH,Nahrig J,et al. Prognostic significance of expression patterns of c-erbB-2,p53, p16INK4A,p27KIP1,cyclin D1 and epidermal growth factor receptor in oesophageal adenocarcinoma:a tissue microarray study[J]. J Clin Pathol,2006,59(6):631-634. [20] Mesteri I,Schoppmann SF,Preusser M,et al. Overexpression of CMET is associated with signal transducer and activator of transcription 3 activation and diminished prognosis in oesophageal adenocarcinoma but not in squamous cell carcinoma[J]. Eur J Cancer,2014,50(7):1354-1360. |